Literature DB >> 15036556

Neuroprotection in ophthalmology: a review.

Yaniv Barkana1, Michael Belkin.   

Abstract

Evidence has accumulated that damaged neural cells may not inevitably degenerate, and that in vivo cells which are not directly injured by an insult may be adversely affected by adjacent dying cells. Neuroprotection is a strategy which aims to maximize recovery of injured neural cells and minimize secondary damage to neighboring cells. In this work, we review the current knowledge from neuroprotection research using in vitro and animal models of eye diseases, and clinical data.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036556     DOI: 10.1016/S0361-9230(03)00071-6

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  12 in total

1.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.

Authors:  Michael S Ip; Ingrid U Scott; Paul C VanVeldhuisen; Neal L Oden; Barbara A Blodi; Marian Fisher; Lawrence J Singerman; Michael Tolentino; Clement K Chan; Victor H Gonzalez
Journal:  Arch Ophthalmol       Date:  2009-09

2.  Cortisol promotes survival and regeneration of axotomised retinal ganglion cells and enhances effects of aurintricarboxylic acid.

Authors:  Peter Heiduschka; Solon Thanos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-28       Impact factor: 3.117

3.  Edible seaweed, Eisenia bicyclis, protects retinal ganglion cells death caused by oxidative stress.

Authors:  Kyung-A Kim; Sang Min Kim; Suk Woo Kang; Sang Il Jeon; Byung Hun Um; Sang Hoon Jung
Journal:  Mar Biotechnol (NY)       Date:  2012-05-18       Impact factor: 3.619

4.  Aqueous humor hepcidin prohormone levels in patients with primary open angle glaucoma.

Authors:  Rana Sorkhabi; Amir Ghorbanihaghjo; Alireza Javadzadeh; Behzad Fallahi Motlagh; Solmaz Shoa Ahari
Journal:  Mol Vis       Date:  2010-09-07       Impact factor: 2.367

5.  Diazoxide is protective in the rat retina against ischemic injury induced by bilateral carotid occlusion and glutamate-induced degeneration.

Authors:  T Atlasz; N Babai; D Reglodi; P Kiss; A Tamas; F Bari; F Domoki; R Gabriel
Journal:  Neurotox Res       Date:  2007-09       Impact factor: 3.911

6.  Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the PKA-Bad-14-3-3 signaling pathway in glutamate-induced retinal injury in neonatal rats.

Authors:  Boglárka Rácz; Ferenc Gallyas; Péter Kiss; Andrea Tamás; Andrea Lubics; István Lengvári; Erzsébet Röth; Gábor Tóth; Orsolya Hegyi; Zsófia Verzál; Csaba Fabricsek; Dóra Reglódi
Journal:  Neurotox Res       Date:  2007-09       Impact factor: 3.911

Review 7.  Neuroprotection in glaucoma.

Authors:  Sushil K Vasudevan; Viney Gupta; Jonathan G Crowston
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

8.  The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation.

Authors:  Somaia Mitne; Sergio Henrique Teixeira; Michal Schwartz; Michael Belkin; Michel Eid Farah; Nilva S Bueno de Moraes; Luciana da Cruz Nóia; Angela Tavares Paes; Cláudio Luiz Lottenberg; Augusto Paranhos Júnior
Journal:  Clin Ophthalmol       Date:  2011-07-15

9.  Effects of combined ketamine/xylazine anesthesia on light induced retinal degeneration in rats.

Authors:  Blanca Arango-Gonzalez; Andreas Schatz; Sylvia Bolz; Javier Eslava-Schmalbach; Gabriel Willmann; Ahmad Zhour; Eberhart Zrenner; M Dominik Fischer; Florian Gekeler
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

10.  Neurodegenerative diseases of the retina and potential for protection and recovery.

Authors:  K-G Schmidt; H Bergert; R H W Funk
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.